Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
A drug that could save the sight of people with diabetes will not be made available on the NHS in England and Wales, an advisory body has concluded.
The National Institute for Health and Clinical Excellence (NICE) says ranibizumab, sold under the brand name Lucentis, is too expensive to use in people with diabetic macular oedema.
Charities say they will continue to campaign for the drug to be used.
At least 50,000 people in the UK are affected by this eye condition.
http://www.bbc.co.uk/news/health-15939072
The National Institute for Health and Clinical Excellence (NICE) says ranibizumab, sold under the brand name Lucentis, is too expensive to use in people with diabetic macular oedema.
Charities say they will continue to campaign for the drug to be used.
At least 50,000 people in the UK are affected by this eye condition.
http://www.bbc.co.uk/news/health-15939072